ConductScience.org, home

Paper39903487

Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.

Desouter AK and 16 others. Diabetes Care, 2025. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis. Papers, record 39903487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39903487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.
PubMed
Journal
Diabetes Care
PubMed
Year
2025
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
5.08, provisional
iCite
Revised in PubMed
2025-06-12
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Desouter AKAster Khttps://orcid.org/0000-0001-9070-3882
2Keymeulen BBarthttps://orcid.org/0000-0002-8671-4527
3Van de Velde UUrsule
4Van Dalem AAnnelienhttps://orcid.org/0000-0003-2304-5298
5Lapauw BBrunohttps://orcid.org/0000-0002-1584-4965
6De Block CChristophehttps://orcid.org/0000-0002-0679-3203
7Gillard PPieterhttps://orcid.org/0000-0001-9111-4561
8Seret NNicole
9Balti EVEric Vhttps://orcid.org/0000-0003-4445-308X
10Van Vooren ERElena R
11Staels WWillemhttps://orcid.org/0000-0001-8259-3329
12Van Aken SSarahttps://orcid.org/0000-0001-8629-254X
13den Brinker MMariekehttps://orcid.org/0000-0001-9278-8795
14Depoorter SSylvia
15Marlier JJokehttps://orcid.org/0000-0002-9500-608X
16Kahya HHasanhttps://orcid.org/0009-0003-0974-3054
17Gorus FKFrans Khttps://orcid.org/0000-0002-9007-6177

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Blood GlucoseMajor topic
Blood Glucose Self-MonitoringMajor topic
Humans
Glucose Tolerance Test
Male
Female
Longitudinal Studies
Adolescent
Child
Glycated Hemoglobin
Adult
Young Adult
Disease Progression
Continuous Glucose Monitoring

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Junior research fellowship 11D1214NFonds Wetenschappelijk OnderzoekPubMed
IWT 130 138Departement Economie, Wetenschap en InnovatiePubMed
Funding for the Belgian Diabetes RegistryWetenschappelijk Fonds Willy Gepts, Universitair Ziekenhuis BrusselPubMed
Funding for the Belgian Diabetes RegistryCenter for Medical Innovation FlandersPubMed
Free-of-charge materials. No other involvement.Medtronic EuropePubMed
Free-of-charge materials. No other involvement.BayerPubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123780460Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.JAMA2013https://conductscience.org/library/papers/23780460PubMed
215613948Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.Epidemiology2005https://conductscience.org/library/papers/15613948PubMed
317182981Relaxing the rule of ten events per variable in logistic and Cox regression.Am J Epidemiol2007https://conductscience.org/library/papers/17182981PubMed
432457058C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet.Diabetes Care2020https://conductscience.org/library/papers/32457058PubMed
530556249Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study.Pediatr Diabetes2019https://conductscience.org/library/papers/30556249PubMed
633179853Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study.Pediatr Diabetes2021https://conductscience.org/library/papers/33179853PubMed
719469679Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control.Diabetes Technol Ther2009https://conductscience.org/library/papers/19469679PubMed
836459177The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes.Diabetologia2023https://conductscience.org/library/papers/36459177PubMed
936326757Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.Diabetes Care2022https://conductscience.org/library/papers/36326757PubMed
1026404926Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Diabetes Care2015https://conductscience.org/library/papers/26404926PubMed
1131180194An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.N Engl J Med2019https://conductscience.org/library/papers/31180194PubMed
1234880069CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.Diabetes Care2022https://conductscience.org/library/papers/34880069PubMed
1325524912HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk.Diabetes2015https://conductscience.org/library/papers/25524912PubMed
1436730530CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.Diabetes Care2023https://conductscience.org/library/papers/36730530PubMed
1539642898Dysglycaemia definitions and progression to clinical type 1 diabetes in children with multiple islet autoantibodies.Lancet Diabetes Endocrinol2025https://conductscience.org/library/papers/39642898PubMed
1630089716β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis.JCI Insight2018https://conductscience.org/library/papers/30089716PubMed
1739159241Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes.Diabetes Care2024https://conductscience.org/library/papers/39159241PubMed
1825985749OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis.Diabetologia2015https://conductscience.org/library/papers/25985749PubMed
1926409458Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.Diabetologia2015https://conductscience.org/library/papers/26409458PubMed
2021972409Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.Diabetes Care2011https://conductscience.org/library/papers/21972409PubMed

See all 36 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42450641Glucose Dysregulation as a Driver of Autoimmune Mimicry, Inflammation, and Psychiatric Symptoms: A Narrative Review.Biology (Basel)2026https://conductscience.org/library/papers/42450641PubMed
42149241GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.Diabetologia2026https://conductscience.org/library/papers/42149241PubMed
41913320Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy.Diabetes Obes Metab2026https://conductscience.org/library/papers/41913320PubMed
41803288Continuous glucose monitoring as a tool in early-stage type 1 diabetes.Diabetologia2026https://conductscience.org/library/papers/41803288PubMed
41618706Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta-analysis.Diabet Med2026https://conductscience.org/library/papers/41618706PubMed
41535597Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.Diabetologia2026https://conductscience.org/library/papers/41535597PubMed
41317333Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening.Endocrinol Diabetes Metab2026https://conductscience.org/library/papers/41317333PubMed
41211799Optimizing Type 1 Diabetes Screening in People With Family History: A German Perspective.J Diabetes Sci Technol2025https://conductscience.org/library/papers/41211799PubMed
41157252Continuous Glucose Monitoring in People at High Risk of Diabetes and Dysglycaemia: Transforming Early Risk Detection and Personalised Care.Life (Basel)2025https://conductscience.org/library/papers/41157252PubMed
41137714Are We Ready With Prevention for Type 1 Diabetes?Diabetes Metab Res Rev2025https://conductscience.org/library/papers/41137714PubMed
41035242Continuous glucose monitoring in Korean pediatric patients with type 1 diabetes: current landscape and clinical implications.Clin Exp Pediatr2025https://conductscience.org/library/papers/41035242PubMed
40928674Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.Diabetologia2025https://conductscience.org/library/papers/40928674PubMed
40828811Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study.Diabetes Care2025https://conductscience.org/library/papers/40828811PubMed
40553147Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes.Diabetologia2025https://conductscience.org/library/papers/40553147PubMed
40134221Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening.Diabetes Obes Metab2025https://conductscience.org/library/papers/40134221PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39903487

GET https://conductscience.org/api/papers/v1/39903487/references?page=2